You are here:- Conferences .. HepHIV 2017 Conference .. HepHIV2017: Call to Action

HepHIV 2017: Call for Action


All of us – people living with HIV and with viral hepatitis, civil society representatives, health professionals, public health officers and decision-makers, policymakers, representatives from European and national institutions, and researchers – need to keep collaborating closely to decrease the number of people initiating HIV and HCV treatment late, in order to improve long-term health outcomes and reduce onward transmission.

The year 2016 saw the adoption of the very first global health sector strategy on viral hepatitis, a turning point in efforts to fight the disease, and of a corresponding strategy on HIV. The participants in the HepHIV 2017 Conference call on all stakeholders to work together to achieve the targets and goals in these strategies, and to exceed them when possible, by implementing the following actions.

  1. Improve surveillance of viral hepatitis and the late presentation of viral hepatitis, and support ECDC efforts in this area.
  2. Improve the monitoring and evaluation of programmes and services with respect to testing and linkage to care for HIV, viral hepatitis and sexually transmitted infections, (STIs), and promote the sharing of their best practices.
  3. Improve HIV and viral hepatitis testing strategies:
    1. tailor HIV and viral hepatitis screening strategies to each country’s epidemics, including at the subnational level;
    2. expand and support community-based testing for HIV and viral hepatitis by trained laypeople;
    3. make self-testing and self-sampling an integral part of the testing toolkit;
    4. educate general practitioners and other health care providers about testing strategies, including the importance of prompt referral to specialist care, and
    5. facilitate the implementation of indicator condition-guided testing;
    6. develop new, affordable testing diagnostics, and utilize them; and
    7. increase testing frequency and testing at early stages of infection when cost-effective, particularly in high-risk populations.
  4. Create synergies between efforts to tackle communicable and non-communicable diseases by encouraging partnerships and collaborations, including tandem testing,among people working with HIV, viral hepatitis, TB and STIs.
  5. Advocate for stronger political leadership in implementing evidence-based public health interventions by the EU and its member states, as well as by other governments and international agencies in the WHO European Region.
  6. Remove all restrictions on direct-acting antiviral (DAA) therapy for hepatitis C, and make it immediately available for all people living with active hepatitis C.
  7. Drawing on the support and involvement of all stakeholders, urge governments to negotiate effectively to ensure universal access to DAA therapy.
  8. Make pre-exposure prophylaxis (PrEP) available to everyone who needs it, as an integral part of HIV prevention.
  9. Scale up efforts to combat stigma and discrimination by:
    1. telling the 21st century HIV and viral hepatitis story – that diagnosis and treatment can ensure a long and healthy life and stop onward transmission;
    2. normalizing and expanding HIV and viral hepatitis testing; 
    3. promoting national and regional monitoring of stigma, discrimination and unjust criminalization; and
    4. developing more effective interventions to combat stigma, discrimination and unjust criminalization.
  10. Challenge policies that prevent undocumented migrants from accessing HIV and viral hepatitis prevention, testing, treatment and care.
 New EU project
Friday, September 01, 2017

CHIP will be the coordinator for the new EU funded Joint Action INTEGRATE. The launch of INTEGRATE will happen in Brussels 19 September 2017 where the EU commissioner for Food and Health will participate.
Read more here

 Late presentation of chronic viral hepatitis for medical care: a consensus definition
Monday, May 08, 2017

New publication! Late presentation of chronic viral hepatitis for medical care: a consensus definition. Read the full article here.

 Two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL
Tuesday, April 04, 2017

Don't miss out! Join a two-day short course on Introduction to Cost-effectiveness Analysis for Infectious Diseases at UCL. The course takes place on 28 and 29 September 2017. Read more here.

 Evaluation of the HepHIV 2017 Conference
Monday, April 03, 2017

The evaluation report from the HepHIV conference is now available. You can access it here.

 The HIV in Europe 2016 Annual Report is now available!
Monday, April 03, 2017

You can now read about our 2016 projects, activities and achievements in our annual report. Find it here.

 New report: The HIV in Europe initiative - the first 10 years
Tuesday, January 31, 2017

2017 marks 10 years of HIV in Europe - read about the 10 years of working with different stakeholders to promote earlier testing and care in our new report

 HepHIV 2017 Malta Conference
Tuesday, January 31, 2017

HepHIV 2017 Conference is now taking place in Malta (31 January - 2 February 2017). See full programme here. You can also follow news and updates on Twitter by following the conference hashtag #HepHIV2017


Copyright 2009 by HIV in Europe